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Abstract
A reverse microemulsion synthesis was used to prepare amine functionalized silica nanoparticles
of three distinct sizes (i.e., 50, 100, and 200 nm) with identical amine concentrations. The
resulting hybrid nanoparticles, consisting of N-(6 aminohexyl) aminopropyltrimethoxysilane and
tetraethoxysilane, were highly monodisperse in size. N-diazeniumdiolate nitric oxide (NO) donors
were subsequently formed on secondary amines while controlling reaction conditions to keep the
total amount of nitric oxide (NO) released constant for each particle size. The bactericidal efficacy
of the NO releasing nanoparticles against Pseudomonas aeruginosa increased with decreasing
particle size. Additionally, smaller diameter nanoparticles were found to associate with the
bacteria at a faster rate and to a greater extent than larger particles. Neither control (non-NO-
releasing) nor NO releasing particles exhibited toxicity towards L929 mouse fibroblasts at
concentrations above their respective minimum bactericidal concentrations. This study represents
the first investigation of the bactericidal efficacy of NO-releasing silica nanoparticles as a function
of particle size.
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The endogenous free radical nitric oxide (NO) is involved in numerous physiological
processes, including neurotransmission, wound healing, blood pressure regulation, platelet
adhesion, and the immune response.1-5 While the delivery of exogenous gaseous NO has
been shown to elicit promising antimicrobial effects against Gram positive and Gram
negative bacteria, and even antibiotic resistant strains,6 the utility of NO as an effective
therapeutic has been limited due to its reactive and concentration dependent behavior. As a
result, much research has focused on the development of NO donors that store and generate
NO in a controlled manner.7-11 Examples of NO donors that reversibly bind NO include
metal nitrosyls, S nitrosothiols, N-diazeniumdiolates, and organic nitrates. N-
Diazeniumdiolate NO donors, formed upon the reaction of secondary amines with NO under
basic conditions, are of particular interest as they undergo proton initiated decomposition in
physiological solution (pH 7.4, 37 °C) to release two equivalents of NO per functional
group.7
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Although useful as tools for studying the role of NO in biology, most low molecular weight
(LMW) NO donors release NO indiscriminately with undesirable cytotoxicity to healthy
cells.3, 12, 13 Previously we reported the synthesis of macromolecular NO releasing silica
particles via the Stöber method as a new class of NO release materials that store/release
substantial levels of NO with great potential for future targeting strategies due to versatile
surface chemistries for attaching cell targeting and/or tracking (i.e., fluorescent)
ligands.14, 15 Employing a hybrid silica design allowed for a wide range of NO doses and
release kinetics by changing the type and concentration of the aminosilane precursor. In a
subsequent study,13 we observed that the silica particles were highly effective at delivering
NO to bacteria (i.e., Pseudomonas aeruginosa), and were thus significantly more
bactericidal than a comparable small molecule NO donor. Our work was corroborated by
other recent reports describing the use of nanomaterials to deliver antimicrobial agents.16
Indeed, nanoparticles composed of silver,17-20 copper,21-23 zinc oxide,24-28 titanium
dioxide,24, 29, 30 and magnesium oxide exhibit a broad range of bactericidal activity. The
bactericidal efficacy of such materials has been proven to be dependent on both the chemical
composition and the particle diameter, with smaller diameters generally enhancing killing.
Morones et al. reported more effective Escherichia coli (E. coli) killing by smaller diameter
(~1–10 nm) silver nanoparticles due to greater particle interaction with the bacteria.17
Likewise, Nair et al. observed tunable killing as a function of particle size for zinc oxide
nanoparticles, with the greatest killing efficacy observed for the smallest particle system
prepared.28 Since particle association with bacteria appears to be critical to antimicrobial
activity,17, 31-33 we sought to study the influence of nanoparticle size on nanoparticle
bacteria interactions and the resulting bactericidal efficacy of NO-releasing nanoparticles.
Herein, we describe the reverse microemulsion synthesis of monodisperse NO-releasing
silica particles of three distinct sizes (50, 100, and 200 nm) with equal NO release and the
evaluation of their size dependent antibacterial action against Pseudomonas aeruginosa.
RESULTS AND DISCUSSION
While metallic and metal oxide nanoparticles with diameters of 1 to 500 nm have been
reported to exhibit toxicity towards both Gram-positive and Gram negative microorganisms,
nanoparticles of diameters ≤100 nm are generally more effective biocides.16 As such, we set
out to investigate the influence of particle size on the bacteria killing efficacy of NO
releasing silica particles with diameters above, below, and equal to 100 nm. To achieve
these specific sizes, the reverse microemulsion technique was used as it provides a method
for synthesizing silica based particles in the nanometer range with excellent control over size
and particle composition by changing any number of synthetic parameters including the
amount of water and ammonium hydroxide,34-36 reaction time, the type of organic solvent,
and the ratios of water to surfactant, surfactant to co surfactant, and surfactant to organic
solvent.36-38 A clear benefit of this method is the ability to tune particle size while keeping
the aminoalkoxysilane:alkoxysilane ratio constant.34, 39-41 In general, particles synthesized
by the reverse microemulsion method have a smaller size and narrower distribution than
those produced via the Stöber method.37, 42 Narrow size distributions are essential when
investigating the influence of nanoparticle size on bacterial interactions. Furthermore, the
use of the reverse microemulsion technique provides a facile method for core shell particle
designs such that a variety of functionalities are easily incorporated as part of the silica
scaffold.34, 37, 39-41, 43
Size-Controlled Synthesis of Amine-Functionalized Silica Nanoparticles
Scheme 1 illustrates the reverse microemulsion approach used to obtain amine
functionalized silica nanoparticles. For the three sizes (50, 100, and 200 nm), the micelles
were prepared using Triton X-100 (surfactant) and 1-hexanol (co surfactant) suspended in
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pentane or heptane. Following micelle formation, an aqueous phase was introduced by
adding water and ammonium hydroxide, sequentially. Following the formation of a stable
microemulsion as indicated by a clear and colorless solution (step 1 of Scheme 1), the amine
modified silica nanoparticles were synthesized. N-(6
aminohexyl)aminopropyltrimethoxysilane (AHAP) and tetraethoxysilane (TEOS) were
chosen for study based on prior work that demonstrated NO-releasing AHAP/TEOS
particles to be effective against P. aeruginosa and not toxic to fibroblast cells.13 The
addition of pure aminosilane to the microemulsion resulted in amorphous silica particulates
at low yields (1–2 mg). Thus, it was necessary to include a tetraalkoxysilane backbone to
promote condensation as was seen for our previously reported particle systems.14, 15
However, the simultaneous addition of both AHAP and TEOS resulted in particles of a wide
size distribution, especially at high AHAP concentrations. By adopting a sequential silane
addition method, the monodispersity of the particles was greatly improved. Thus, TEOS was
added initially to the microemulsion to form monodisperse TEOS seed particles (step 2 of
Scheme 1) prior to shell modification with 65 mol % AHAP (balance TEOS), as shown in
step 3 of Scheme 1. The reverse microemulsion process allowed for higher aminosilane
incorporation than was previously achievable via the Stöber process (10 mol %, balance
TEOS)14 due to diffusion controlled particle growth. Of note, adding AHAP alone to the
microemulsion resulted in poor shell formation and low yield. Due to the mismatched
hydrolysis and condensation rates of the two silane precursors,44 TEOS was added 30 min
prior to the addition of AHAP during shell modification to achieve monodisperse particle
populations.
To tune particle size, a variety of synthetic parameters were adjusted (Table 1). The
viscosity, polarity and molecular structure of the organic solvent are known to influence the
intermolecular forces between the surfactant molecules and the organic phase, and thus
greatly impact the micelle diameter and the resulting particle size.45 Smaller organic solvent
molecules can penetrate deeper into the surfactant layer, decreasing the overall size of the
water droplet and ensuing particles.37 For this reason, pentane was used to prepare the
smallest AHAP/TEOS particles (50 nm), while heptane was used to form the larger diameter
particles (i.e., 100 and 200 nm). Thus, increasing reaction time can ultimately lead to larger
particles.37 For example, a 3 h TEOS seed reaction resulted in 5 nm particles whereas 12 nm
seed particles were achieved after 18 h under the same solvent conditions. Additionally,
increasing the volume of organic solvent decreased the occurrence of interdroplet
percolation, resulting in smaller particles.
The resulting particle sizes and surface charges of the three synthesized systems are
provided in Table 2. While electron microscopy provided a means to examine particle
morphology, dynamic light scattering (DLS) allowed for the measurement of the
hydrodynamic diameter and solution behavior of the particles.46 When interpreting
nanoparticle size, both DLS and electron microscopy data must be considered together for
proper size characterization as particle size measurements from DLS better represent the
entire particle population and the actual size in solution. The Z average diameter,
polydispersity index (PDI), and particle size distributions (PSD), and diameters as measured
from transmission electron microscopy (TEM) are provided in Table 2. Taken together, the
parameters reported in Table 2 provide a comprehensive evaluation of the actual particle
sizes present during bacteria assays. Although no official standard exists, a PDI of <0.2 is
considered to be monodisperse, while a PDI ≤0.1 is considered to be highly monodisperse.47
With respect to the synthesized silica particles, we observed increasing PDI values as the
particle diameter decreased, indicating that while all sizes were monodisperse and formed
stable suspensions in PBS, decreasing particle size resulted in a slight increase in size
distribution. This monodispersity was further corroborated by TEM (Table 2; Supporting
Information). Collectively, the DLS and TEM data indicate that these particle systems are
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suitable for investigating the influence of particle size on particle bacteria interactions based
on their narrow size distribution and solution stability.
Solid state 29Si nuclear magnetic resonance (NMR) confirmed the covalent incorporation of
the aminosilane into the silica network. Cross polarization (CP) and magic angle spinning
(MAS) techniques were used to enhance the sensitivity toward silicon atoms near CHx or
OH groups and improve peak resolution.48, 49 As shown in Figure 1, the spectrum of each
particle system contained both T and Q bands, representing silicon atoms that are bound to
three (AHAP) and four (TEOS) oxygen atoms, respectively. Changes in the neighboring
oxygen environments surrounding the observed silicon atom were indicated by peak
splitting within the T and Q bands denoted by superscripted numbers corresponding to the
number of siloxane bonds.48 The 29Si NMR spectra therefore confirmed successful co
condensation and incorporation of AHAP and TEOS into the scaffold for each particle size.
Of note, the ratios of the T band to Q band intensities are not reflective of the actual ratios of
AHAP to TEOS within the particle because the core particles are likely pure SiO2 and free
of hydrogens.
Elemental analysis allowed for a more quantitative investigation of AHAP concentration
within each particle system. We hypothesized that the amine content would remain constant
regardless of particle diameter because the molar amounts of silane precursors (both TEOS
and AHAP) were held constant for all three systems. Furthermore, the wt% N measured
from CHN analysis may be translated to AHAP concentration as it is the only nitrogen
contributing component within the silica network. For the smallest particle system (50 nm),
we measured a wt% N of 5.39, corresponding to 1.93 μmol AHAP per mg of particles.
While the nitrogen amount increased slightly for the 100 nm particles (6.64 wt% N or 2.37
μmol AHAP per mg of particles), the larger 200 nm particle system was characterized by a
slightly lower nitrogen content (5.29 wt% N corresponding to 1.89 μmol N per mg of
particles), indicating a similar amine content regardless of a change in particle size for the
three systems synthesized here.
N-Diazeniumdiolate NO Donor Functionalization
Nitric oxide was loaded onto the silica scaffolds via N diazeniumdiolate formation on the
secondary amine sites of AHAP by exposing the particles to high pressure of NO in the
presence of a base catalyst (NaOMe) (Scheme 2).14, 50 Relative to Stöber prepared
particles,14 we attribute the greater NO storage achieved for the microemulsion formed
AHAP/TEOS particles (Table 2) to greater AHAP loading.
N-diazeniumdiolate formation was confirmed via NO release and zeta potential (i.e., surface
charge) changes observed after NO loading (Table 2). Initially, each particle system was
characterized by a slightly positive charge of ca. +12 mV, an expected result due to the
protonated primary amines at pH 7.4. Following NO loading, the zeta potential for each size
became neutral (zeta potential between 10 and +10 mV)51 from the contribution of the
zwitterionic N-diazeniumdiolate functionality (Scheme 2). The particles regained their
positive charge within 10 min as the result of N-diazeniumdiolate decomposition and
regeneration of parent amines.
As shown in Table 3, the total amount of NO released from the particles was 1.49±0.29,
1.26±0.17, and 1.01±0.08 μmol mg−1 for the 50, 100, and 200 nm AHAP/TEOS particles,
respectively. Based on the AHAP content per mg particle (Table 3), NO donor loading
efficiencies were determined to be 38.6, 26.6, and 26.7% for 50, 100, and 200 nm particles,
respectively. Such NO loading efficiency is consistent with previously reported N-
diazeniumdiolate modified silica particles.14, 50 The greater conversion efficiency for the
smallest particle size may be attributed to the increased surface area to volume ratio,
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resulting in a larger concentration of amines nearer to the particle surface and therefore more
accessible to reaction. These hybrid silica particles have very low porosity with surface
areas (SBET) of 4–20 m2/g and pore volumes of 0.008-0.989 cm3/g (at p/po = 0.99) as
determined from nitrogen adsorption desorption isotherms. Indeed, the high density and low
porosity resulting from the co condensation method used to synthesize amine modified
hybrid silica materials have been previously observed.14, 15 As a result of low porosity,
amine sites farther from the particle surface are less accessible to diazeniumdiolation. To
ascertain the dose of NO delivered from the particles over the course of the bactericidal
assays, the total amounts of NO released over 2 and 24 h were measured and are provided in
Table 3. As expected, each particle system was depleted of NO by 24 h. The NO release
data indicates that over the course of 24 h, bacteria were exposed to similar amounts of NO
regardless of nanoparticle size as there is no statistical difference in the total amount of NO
released from each particle system. Since NO release occurs upon protonation of the
secondary amine of the N-diazeniumdiolate, it is inevitable that the kinetics of NO release
differ slightly for each particle size based on the N-diazeniumdiolate groups’ proximity to
the particle surface and therefore differing rate of contact with the aqueous solvent. As
shown in Figure 2, the instantaneous release of NO from the particles was characterized by
an initial burst of NO due to immediate decomposition of surface N-diazeniumdiolate NO
donors upon solution immersion. This instantaneous maximum concentration of NO release
is defined as [NO]m. The particles exhibited a [NO]m of 49.7, 43.5, and 44.7 ppm mg−1
from the 50, 100, and 200 nm particles, respectively.
Effect of Nanoparticle Size on Bactericidal Activity against Pseudomonas aeruginosa
Based on prior work suggesting particles less than 100 nm are more effective antimicrobial
materials,16 we hypothesized that the 50 nm NO releasing silica nanoparticles would be
more effective at bacteria killing than the larger 100 and 200 nm particles. Minimum
bactericidal concentration (MBC) assays were performed under nutrient free conditions in
phosphate buffered saline (PBS) to eliminate bacteria replication as our goal was to more
accurately emphasize the role of size on the particle’s bactericidal activity. The MBC was
determined as a function of NO releasing nanoparticle size against 106 colony forming units
(CFU) mL−1 P. aeruginosa cultures. The minimum particle concentrations required to
achieve complete killing (3 log reduction) after short (2 h) and long (24 h) exposures were
thus determined using bacteria in the healthiest state (i.e., mid log growth stage).52 After 2 h,
the smaller particles were notably more effective at killing P. aeruginosa compared to larger
particles (MBC2h of 0.8 mg mL−1 for 50 nm versus 1.5 mg mL−1 for 100 and 200 nm NO
releasing AHAP/TEOS particles, respectively). This two fold difference in MBC2h is
significant given that there is only a slight difference in total NO released after 2 h from
each particle size (Table 3). The total NO released from each particle size after 24 h was not
statistically different, yet a two fold difference in MBC24h was still observed. Furthermore,
the increased NO release exposure resulted in nearly a 4 fold decrease in the particle
concentrations required to kill P. aeruginosa with MBC24h of 0.2 mg mL−1 for 50 and 100
nm and 0.4 mg mL−1 for 200 nm NO releasing particles. Of note, the 100 nm particles
exhibited similar bactericidal properties as the 200 nm particles at short incubation times,
while at longer periods the bactericidal efficacy of the 100 nm particles resembled that of the
50 nm nanoparticles. This data corroborates the well known relationship between biocidal
activity and materials in the nanoscale (i.e., materials with size measuring 100 nm or less in
one dimension). The considerable decrease in MBC over time indicates that the efficacy of
the NO releasing nanoparticles improves as more NO is released. Neither blanks (i.e., in
PBS only) nor control (non NO releasing) AHAP/TEOS particles at MBC concentrations
affected P. aeruginosa viability (Supporting Information).
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Although the observed relationship between particle size and MBC may be expected, the
mechanism for this phenomenon remained uncertain. Confocal microscopy was thus used to
qualitatively observe particle fate. To allow for visualization using fluorescence imaging, the
surface accessible primary amines of the AHAP particles were chemically modified with
rhodamine isothiocyanate (RITC).53 Although NO release was decreased slightly (by 9%),
no change in particle size or particle surface charge was observed following RITC
modification. Similar to the non fluorescent particles, a slight decrease in zeta potential was
noted following diazeniumdiolation of the RITC modified particles (ca. +13 mV to ca. +7
mV for control and NO releasing, respectively). Initially, a time based experiment was
conducted where the bacteria were treated with RITC modified NO releasing AHAP/TEOS
particles, and images were collected at 20 sec intervals over the course of 40 min. The
particles rapidly associated with the bacteria within 2 min (Supporting Information), a
favorable attribute given the bolus release of NO. Immediately following this interaction,
membrane degradation, cellular collapse, blebbing and decreased adhesion to the substrate
were observed and attributed to the antimicrobial action of NO (e.g., lipid peroxidation)
(Supporting Information).54 Such severe morphological changes hindered our ability to
distinguish between individual bacteria cells. Thus, the remaining confocal experiments
were carried out using RITC modified control AHAP/TEOS particles to maintain bacteria
viability and potentially glean information on particle bacteria association. Given that the
size and surface charge are similar between the NO releasing and control RITC modified
particles, particle bacteria interactions that occur with control particles are an accurate
representation of those that occur with NO releasing RITC particles. When P. aeruginosa
were exposed to particles at 50 μg mL−1 for longer than 30 min, fluorescence was present in
all bacteria regardless of the particle size. By exposing the bacteria to decreased doses of 50,
100, and 200 nm RITC modified nanoparticles (i.e., 10 μg mL−1) for shorter time (i.e., 10
min), a difference in the rate and extent of association was observed fluorescently (Figure
3). The greatest RITC fluorescence was observed upon treatment of bacteria with the 50 nm
nanoparticles (Figure 3A). Bacteria exposed to 100 nm nanoparticles exhibited some
fluorescence but at a lower magnitude than the 50 nm treated cells (Figure 3B). Finally, little
fluorescence was observed from the cells treated with the 200 nm particles (Figure 3C).
Collectively, these results indicate that although all particle systems tested interact with the
bacteria, the smaller diameter particles do so more rapidly. As shown in the inset of Figure 2
and provided in Table 3, a large amount of NO is released within the initial 10 min.
Therefore, the rate of association governs the amount of NO delivered to the bacteria.
Greater association with decreasing particle diameter corroborates our finding that smaller
particles were more bactericidal at lower concentrations than larger particles. Indeed, the
faster diffusion rate of smaller particles allows for a more rapid association with bacteria. As
such, a larger portion of the stored NO is likely delivered to the bacteria from the 50 nm
particles compared to the 100 and 200 nm particles, thereby lowering the necessary particle
and overall NO concentrations required for effective killing.
Cytotoxicity against L929 Mouse Fibroblasts
The use of NO donor functionalized silica scaffolds is motivated by both the synthetic
versatility and biologically inert qualities of silica.55 To be useful as a potential therapeutic,
such materials must possess favorable toxicity to normal cells. The cytotoxicity of both NO
releasing and control AHAP/TEOS particles was thus evaluated against L929 mouse
fibroblasts. Fibroblast viability screening represents a first test for evaluating cytotoxicity of
both systemic and topical antibacterial agents as these cells play a critical role in wound
healing.56, 57 Although our lab has previously observed that AHAP/TEOS particles
synthesized via the Stöber method exhibited no toxicity toward fibroblast cells,13 the
cytotoxicity of the particles reported herein was not obvious due to the modified synthesis
(i.e., reverse microemulsion). In addition, our prior report did not investigate the role of size
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on toxicity. The MTS assay was used to measure cell viability after exposure to both control
and NO releasing particles for 2 and 24 h to mimic the two exposure times of the
bactericidal assays. Particle concentrations up to double the MBC values for each time point
were tested to evaluate cytotoxicity above the concentration required for bacteria killing.
Theoretical total NO doses delivered from each particle concentration after 2 and 24 h were
calculated from the NO release data (Table 3) and are provided as Supporting Information.
As shown in Figure 4A, no toxicity was observed after 2 h from the NO releasing particles
up to their respective MBC2h doses regardless of particle size. Control particles of 50 and
100 nm were also not toxic at their respective bactericidal concentrations. However, the
MBC2h dose of control 200 nm particles (1.6 mg mL−1) decreased fibroblast viability by
36%. Although toxicity was observed at the highest concentration tested (3.2 mg mL−1) for
control 50 nm and both NO releasing and control 200 nm particles, we note that these
concentrations were well above the therapeutic doses required for complete bacteria killing
(0.8 and 1.5 mg mL−1, respectively). As shown in Figure 4B for 24 h treatment, no
significant toxicity was observed for either NO releasing or control particles at
concentrations up to 2× MBC24h for all three sizes. Taken together, these results indicate
that increased treatment time with NO releasing AHAP/TEOS particles has the combined
advantage of lower therapeutic dose required for sufficient bacteria killing with negligible
effect on fibroblast cell viability.
CONCLUSION
A reverse microemulsion synthesis was developed to prepare three sizes of highly
monodisperse aminosilane modified silica nanoparticles. The particles were characterized by
high amine loading with surface accessible primary amines that allowed for straightforward
coupling of fluorescent markers. Conjugation of other biorecognition agents should be
compatible in the same way, further expanding the potential therapeutic utility of these
scaffolds. By maintaining constant NO loading/release for each particle size, the relationship
between nanoparticle size and bactericidal efficacy was probed. At shorter exposure time,
the smaller NO releasing silica nanoparticles (50 nm) were found to exhibit the greatest
bactericidal activity. Such behavior may be attributed to their increased rate of association
and subsequent greater NO payload delivered directly to the bacteria. We hypothesize that
increasing the rate at which NO releasing particles associate with bacteria may further
improve their antibacterial properties. Future research should focus on how the amount and
kinetics of NO delivered into bacterial cells influences the observed bactericidal efficacy.
Although particles with both neutral and positive surface charges were shown to interact
with the bacteria, the rate of particle association is likely influenced by particle surface
charge as bacteria are characterized by a net negative charge. More effective antibacterial
nanoparticle therapeutics may be realized by understanding the role of particle bacteria
interactions on bactericidal activity.
EXPERIMENTAL SECTION
Materials
Tetraethoxysilane (TEOS) and N-(6 aminohexyl)aminopropyltrimethoxysilane (AHAP)
were purchased from Gelest (Morrisville, PA). Triton X-100, 1 hexanol, heptane, pentane,
sodium methoxide (NaOMe, 5.4 M solution in methanol), dimethylformamide, methanol,
and rhodamine isothiocyanate were purchased from Acros Organics (Morris Plains, NJ).
Ethanol, butanol, and 1 propanol were purchased from Fisher Scientific (Fair Lawn, NJ).
Tryptic soy broth, tryptic soy agar, and minimum essential media (MEM) were purchased
from Becton, Dickinson and Company (Sparks, MD). Pseudomonas aeruginosa (ATCC
#19143) was purchased from American Type Culture Collection (Manasses, VA). L929
mouse fibroblasts were obtained from the UNC Tissue Culture Facility (Chapel Hill, NC).
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Nitric oxide (99.5%), nitrogen (N2), and argon (Ar) gases were purchased from National
Welders (Raleigh, NC). Distilled water was purified using a Millipore Milli Q UV Gradient
A 10 system (Bedford, MA) resulting in a total organic content of ≤6 ppb and a final
resistivity of 18.2 mΩ·cm.
Reverse Microemulsion Synthesis of Amine-Functionalized Silica Nanoparticles
Amine functionalized silica nanoparticles of select sizes were synthesized by adjusting the
type and volume of organic solvent used in the reverse microemulsion.37, 40, 43 Initially,
reverse micelles were formed by mixing 3.54 g Triton X-100, 3.6 mL 1 hexanol, and the
appropriate amount and type of organic solvent for 30 min. Then, 240 μL water, 120 μL
ammonium hydroxide solution (28 wt% in water), and 40 μL TEOS were added sequentially
in 30 min intervals. Hydrolysis and condensation were allowed to proceed for 3 or 18 h,
depending on the desired particle size, to form a TEOS seed particle. The organic solvent
type and volume as well as the reaction time for initial TEOS seed growth for each particle
size are listed in Table 1. Following the formation of the TEOS core particle, an additional
40 μL (0.179 mmol) TEOS was added to the microemulsion, after which 84 μL (0.335
mmol) AHAP was added 30 min later. Hydrolysis and co condensation of TEOS and AHAP
were allowed to proceed for an additional 18 h to form the amine functionalized shell. The
emulsion was broken upon the addition of ethanol. Silica precipitates were collected via
centrifugation at 3645g for 5 min. The supernatant was removed, and the particles were
washed by resuspension in 1 butanol, 2 propanol, and ethanol, sequentially. To ensure
removal of Triton X-100, particles were resuspended in 45 mL of a 50/50 ethanol/water (v/
v) solution, sonicated for 5 min in chilled water, and collected via centrifugation (3645g, 5
min). This process was repeated three times before a final wash with ethanol to aid in drying
of the particles. The resulting surfactant free particles (confirmed by UV Vis) were dried in
vacuo overnight. Product yields were typically between 10–20 mg per reaction.
N-Diazeniumdiolation of Amine-Functionalized Silica Nanoparticles
The procedure for loading NO onto the core shell particles was modified from a previously
reported method.14, 50 Briefly, particles were suspended in a 1:9 mixture of DMF and
methanol (5 mg mL−1) by sonication. Sodium methoxide, the base catalyst (5.4 M in
MeOH), was added in either a 2.5:1 for 50 nm particles or 5:1 for 100 and 200 nm particles
molar ratio relative to the concentration of secondary amines as determined by elemental
analysis. Following thorough mixing of this solution (vortexed for 1 min), 3.5 mL aliquots
were placed in vials equipped with a stir bar. The open vials were then placed in a 160 mL
Parr general purpose stainless steel pressure vessel with magnetic stirring and connected to
an in house NO reactor. Oxygen was removed from the solutions by purging with Ar three
times rapidly, followed by three 10 min Ar purges at 8 bar. The vessel was then filled to a
pressure of 10 bar with NO that had been scrubbed with KOH. The pressure in the reactor
was maintained at 10 bar for 72 by repressuring with fresh NO to accommodate loss due to
reaction and/or gas leak. After 72 h, the NO was released from the vessel, and the solutions
were again purged with Ar to remove unreacted NO. The resulting N-diazeniumdiolate
modified silica nanoparticles were collected by centrifugation (3645g, 5 min), washed three
times with ethanol, and dried in vacuo. The NO donor modified nanoparticles were then
stored in a vacuum sealed package at 20 °C until further use (up to one week). No loss in
NO loading was observed for particles stored in this manner up to 8 d (the longest period
investigated) as determined by chemiluminescence upon comparing NO release immediately
following diazeniumdiolate formation to that measured on day 8.
Nitric Oxide Release Measurements
Total amounts of NO released from each particle size were evaluated using the Griess
assay.58 The NO loaded particles were placed in oxygenated phosphate buffered saline
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(PBS) upon which the liberated NO is oxidized to nitrite (NO2−). After removing the
particles via centrifugation, the supernatant containing NO2− was reacted with 1 wt%
solutions of sulfanilamide and N-1 naphthylethylenediamine to form an azo compound. By
detecting the absorbance at 540 nm and comparing the results to a calibration curve, the
concentration of NO released from the particles is deduced. While the Griess assay allows
for the measurement of total NO concentrations, real time diazeniumdiolate degradation and
NO release kinetics were determined using a Sievers NOA 280i chemiluminescence NO
analyzer (Boulder, CO) in PBS (pH 7.4) at 37 °C, as described previously.59 The absence of
nitrite byproducts was confirmed by equal total NO concentrations measured from the
Griess assay and the NOA. Prior to analysis, the NO analyzer was calibrated with air passed
through a NO zero filter (0 ppm NO) and a 26.39 ppm NO standard gas (balance N2).
Nanoparticle Characterization
The hydrodynamic particle diameter and zeta potential (i.e., surface charge) were measured
using a Malvern Zetasizer Nano ZS (Malvern Instruments, Ltd.; Worcestershire, UK)
equipped with a 10 mW HeNe laser (633 nm) and a NIBS® detector at an angle of 173°. All
samples were prepared at 1 mg/mL concentrations in PBS (size) or phosphate buffer (zeta
potential) and analyzed at 37 °C to mimic the media used for NO release and bacteria
assays. Phosphate buffer (non saline, pH 7.4) was employed for zeta potential measurements
because the high ionic content of PBS was found to corrode the folded capillary
electrodes.51 Particle size and morphology were also characterized using a JEOL 100 CX II
Transmission Electron Microscope (TEM) at 100 kV.
Covalent incorporation of AHAP and TEOS within the silica network was confirmed using
solid state cross polarization/magic angle spinning (CP/MAS) 29Si NMR with a Bruker 360
MHz DMX spectrometer (Billerica, MA) equipped with wide bore magnets (triple axis
pulsed field gradient double resonance probes). Samples were packed into a 4 mm rotor
(double resonance frequency of 71.548 Hz) and spun at a speed of 10 kHz. Chemical shifts
were determined in parts per million relative to a tetramethylsilane external standard.
Elemental analysis was performed using a PerkinElmer CHN/S O Elemental Analyzer
Series 2400 (Waltham, MA) instrument.
Bactericidal Assays
Pseudomonas aeruginosa was cultured to a concentration of 108 colony forming units
(CFUs) per mL, collected via centrifugation, resuspended in sterile PBS and adjusted to a
concentration of 106 CFU mL−1. This starting concentration was chosen to accurately show
at least 3 logs reduction as the limit of detection for the plate counting method is 2.5×103
CFU mL−1.52 Aliquots of the 106 CFU mL−1 bacteria suspension were added to pre massed
amounts of nanoparticles to obtain the following concentrations 0, 0.025, 0.05, 0.1, 0.2, 0.3,
0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0 mg/mL. The nanoparticle/bacteria suspensions were vortexed
for 30 s to adequately suspend the nanoparticles, then incubated at 37 °C with gentle
agitation. Aliquots were then taken from each suspension after 2 and 24 h and diluted 10 and
100 fold in PBS before plating on tryptic soy agar. Bacterial viability was measured after
incubating plates at 37 °C overnight by counting observed colonies.
Confocal Microscopy Studies
Nanoparticles were fluorescently labeled by covalent modification with rhodamine
isothiocyanate (RITC).53 Briefly, 50 mg of particles were suspended in 100 mL ethanol and
mixed with 5 mg RITC, protected from light, for 48 h. The particles were then washed
copiously with ethanol using the suspension/centrifugation method described above until a
colorless supernatant was achieved. All confocal images were obtained with a Zeiss 510
Meta Laser Scanning Confocal Microscope. Brightfield and fluorescent images (543 nm
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HeNe excitation laser) were collected at room temperature with a N.A. 1.2 C apochromat
water immersion lens with either a 40 or 63× objective as indicated for each image.
Pseudomonas aeruginosa cultures (106 CFU mL−1) were placed in a glass bottom petri dish
and allowed to adhere for 45 min at 37 °C prior to imaging. The slide was then rinsed with
fresh PBS to remove loosely or unadhered bacteria. Brightfield images of untreated bacteria
were obtained as controls. For all experiments, suspensions of rhodamine isothiocyanate
(RITC) modified AHAP/TEOS nanoparticles (500 μL of 10 μg mL−1 in PBS) were added to
the bacteria on the glass slide. To observe association of NO releasing particles with bacteria
over time, fluorescence images were taken immediately following the addition of particles at
20 s intervals for 40 min. To compare the influence of particle size on the extent of particle
bacteria association, fluorescence images were obtained of bacteria treated with 10 μg mL−1
of 50, 100, and 200 nm particles for 10 min. After the 10 min incubation period, the
suspension was removed, and the bacteria were copiously washed with fresh PBS to remove
unassociated particles. Fresh PBS was then added, and the bacteria were imaged.
Cytotoxicity Assays
In vitro cellular toxicity of both control (i.e., control AHAP/TEOS particles) and NO
releasing particles of all three sizes was evaluated using L929 fibroblast cells. Briefly, the
fibroblasts were cultivated in MEM supplemented with 10% fetal bovine serum (v/v, FBS)
and 1% penicillin/streptomycin, then incubated in 5% CO2/95% air under humidified
conditions at 37 °C. After attaining confluency, the cells were trypsinized and then seeded
onto tissue culture treated polystyrene 96 well plates at a density of 3×105 cells mL−1. Three
days later, cells were incubated with control and NO releasing nanoparticles at a
concentration range of 0–3.2 mg mL−1 for 2 h and 0–0.8 mg mL−1 for 24 h. Subsequently,
the particles were aspirated, cells were washed with sterile PBS three times, and 100 μL
fresh media was added to the cells. Cellular viability was assessed using the MTS assay
(CellTiter 96 Aqueous Non Radioactive Cell Proliferation Assay; Promega, Madison, WI).
Briefly, the MTS reagent (20 μL) was added to each well until a purple formazan color was
formed in the control (untreated) wells. The supernatant (90 μL) from each well was then
transferred to a new 96 well plate prior to reading the absorbance at 490 nm using a
microplate reader (Thermoscientific Multiskan® EX; Waltham, MA). Untreated cells were
used as controls and results were expressed as percent viability relative to the untreated
controls.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Solid state CP/MAS 29Si NMR of (A) 50 nm, (B) 100 nm, and (C) 200 nm AHAP/TEOS
nanoparticles. The T band (ca. 70 ppm) represents silicon atoms that are bound to three
oxygen atoms (i.e., AHAP). The Q band (ca. 100 ppm) indicates silicon atoms with four
siloxane bonds (i.e., TEOS).
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Real time NO release profile for 50 (black), 100 (red), and 200 (blue) nm NO releasing
AHAP/TEOS particles from t=0 to t=24 h. Inset: NO release from t=0 to t=0.2 h,
corresponding to the shortest time period at which particle bacteria association was
investigated with confocal microscopy.
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Overlay of fluorescence and brightfield scanning confocal microscopy images of P.
aeruginosa treated with 10 μg mL−1 of (A) 50, (B) 100, and (C) 200 nm RITC modified
AHAP/TEOS silica nanoparticles for 10 min. Magnification is 63×, and scale bar is 5 μm.
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Cytotoxicity of control and NO releasing particles against L929 mouse fibroblast cells as
measured using the MTS assay after (A) 2 h exposure at 0 (white), 0.4 (light grey), 0.8
(grey), 1.6 (dark grey), and 3.2 (black) mg mL−1 and after (B) 24 h exposure at 0 (white),
0.1 (light grey), 0.2 (grey), 0.4 (dark grey), and 0.8 (black) mg mL−1.
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Synthesis of amine functionalized silica nanoparticles via a reverse microemulsion. Step 1
involves micelle formation. Step 2 is the addition of tetraethoxysilane (TEOS) to the
emulsion to form monodisperse “seed” particles. Lastly, step 3 is the subsequent addition of
TEOS and AHAP that co condense to form the AHAP/TEOS silica nanoparticles.
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N-Diazeniumdiolate formation on aminosilane modified silica nanoparticle.
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Table 1




Organic Solvent TEOS Core Particle
Reaction Time
(h)Type Volume(mL)
50 pentane 45.6 3
100 heptane 15.2 3
200 heptane 15.2 18
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